Debiopharm International SA

4:00 PM - 4:15 PM, Monday, June 3, 2019 ・ Theater 4
Debiopharm International SA is focused on the development of prescription drugs that target unmet medical needs in oncology and infectious diseases. The company in-licenses and develops promising drug candidates. The products are commercialized by pharmaceutical out-licensing partners to give access to the largest number of patients worldwide.
Ticker:
Not Provided.
Exchange:
Not Provided.
Company Type:
Company Website:
Company HQ State:
Not Provided.
Company HQ Country:
Switzerland
Year Founded:
1979
Main Therapeutic Focus:
Lead Product in Development:
Debio1143
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided.
Speaker
photo
Director, Business Develoopment & Commercial Insights
Debiopharm International SA